With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
Saul E. Rivkin, MD, Founder of the Marsha Rivkin Center for Ovarian Cancer, Medical Oncologist, Swedish Cancer Institute, Seattle, WA, discusses ovarian cancer and stresses the importance of…
Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses advances in partial breast radiation. References…
A feasibility study presented at the American Association for Cancer Research meeting showed that intraductal chemotherapy may have potential as a treatment for ductal carcinoma in situ and…
A new analysis of data from a multicenter clinical trial suggests that chemotherapy-induced anemia significantly increases the risk of local relapse in premenopausal early-stage breast cancer. References and…
A new study shows that the aromatase inhibitor letrozole can prevent late recurrence of breast cancer. References and Resources Goss P, et al. Late extended adjuvant treatment with…
Statin use at the time of ovarian cancer surgery was associated with a 50% increase in the duration of progression-free survival and with more than a year of…
The Oncologic Drug Advisory Committee said the FDA should mandate a restricted distribution system for cancer patients given erythropoiesis-stimulating agents. References and Resources FDA.gov Sponsored by The Doctor’s…
Results of a Gynecologic Oncology Group study suggest that for patients with recurrent cervical cancer, bevacizumab has demonstrated activity and promise as an option for second or third…
The study provides compelling evidence that diets with a high GI or a high GL will increase the risk of type 2 diabetes and heart disease. References and…
A blood test for mood disorders that enables better diagnosis and treatment may be feasible by extracting RNA to measure the expression of various genes identified as biomarkers…
